Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets.

Full prescribing information is available on request or alternatively please go to www.clonmel-health.ie. Medicinal product subject to medical prescription.

Please contact Clonmel Healthcare on 01-6204000 if you require any additional information.

PA 126/356/1-3. PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary. Date prepared: July 2023. 2023/ADV/RAN/154H.

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets

BOOTS IRELAND LAUNCHES NEW LIVER SCANNING SERVICE

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

Boots Joins Free HRT Scheme, Expanding Access to Essential Healthcare for Women

Pharmacy Professionals Driving Change Recognised at Irish Pharmacy Awards

Skin Cancer and Melanoma

RECOMMENDED NEWS

Genitourinary Syndrome of Menopause (GSM)

Fast, Reliable Blood Testing | Book Your Test Now!

Clonmel Healthcare Ltd wish to inform you of a change in size of Maxilief Effervescent Tablets

Cork Created “Alflorex” wins OTC Award for Best Digestive Product

Quick links

Other info